These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 17107769

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy.
    Fellows P, Price J, Martin S, Metcalfe K, Krile R, Barnewall R, Hart MK, Lockman H.
    Clin Vaccine Immunol; 2015 Sep; 22(9):1070-8. PubMed ID: 26224691
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis.
    Gupta G, Khan AA, Rao DN.
    Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine.
    Griffin K, Bedford R, Townson K, Phillpotts R, Funnell S, Morton M, Williamson D, Titball R.
    FEMS Immunol Med Microbiol; 2005 Mar 01; 43(3):425-30. PubMed ID: 15708318
    [Abstract] [Full Text] [Related]

  • 28. Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation.
    Zhang W, Song X, Zhai L, Guo J, Zheng X, Zhang L, Lv M, Hu L, Zhou D, Xiong X, Yang W.
    Front Immunol; 2022 Mar 01; 13():793382. PubMed ID: 35154110
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.
    Jones T, Adamovicz JJ, Cyr SL, Bolt CR, Bellerose N, Pitt LM, Lowell GH, Burt DS.
    Vaccine; 2006 Mar 06; 24(10):1625-32. PubMed ID: 16243411
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Efficacy of primate humoral passive transfer in a murine model of pneumonic plague is mouse strain-dependent.
    Graham VA, Hatch GJ, Bewley KR, Steeds K, Lansley A, Bate SR, Funnell SG.
    J Immunol Res; 2014 Mar 06; 2014():807564. PubMed ID: 25097863
    [Abstract] [Full Text] [Related]

  • 34. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.
    Levy Y, Flashner Y, Tidhar A, Zauberman A, Aftalion M, Lazar S, Gur D, Shafferman A, Mamroud E.
    Vaccine; 2011 Sep 16; 29(40):6866-73. PubMed ID: 21803090
    [Abstract] [Full Text] [Related]

  • 35. Small protective fragments of the Yersinia pestis V antigen.
    Vernazza C, Lingard B, Flick-Smith HC, Baillie LW, Hill J, Atkins HS.
    Vaccine; 2009 May 11; 27(21):2775-80. PubMed ID: 19366573
    [Abstract] [Full Text] [Related]

  • 36. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L, Manocha M, Sridevi K, Shashikiran D, Rayanade R, Rao DN.
    FEMS Immunol Med Microbiol; 2003 Oct 15; 38(3):215-29. PubMed ID: 14522457
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.
    DeBord KL, Anderson DM, Marketon MM, Overheim KA, DePaolo RW, Ciletti NA, Jabri B, Schneewind O.
    Infect Immun; 2006 Aug 15; 74(8):4910-4. PubMed ID: 16861680
    [Abstract] [Full Text] [Related]

  • 39. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model.
    Williamson ED, Vesey PM, Gillhespy KJ, Eley SM, Green M, Titball RW.
    Clin Exp Immunol; 1999 Apr 15; 116(1):107-14. PubMed ID: 10209513
    [Abstract] [Full Text] [Related]

  • 40. Prospects for new plague vaccines.
    Feodorova VA, Corbel MJ.
    Expert Rev Vaccines; 2009 Dec 15; 8(12):1721-38. PubMed ID: 19943765
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.